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Severe stress may precipitate the onset of schizophrenia or aggravate the symptoms of the illness. 3 In stress, the hypothalamus-pituitary-adrenal axis is activated and it results in an elevated level of circulating adrenal glucocorticoids or stress hormones. 5 Whereas the neurobiological basis of this stress-induced adversity in schizophrenia remains elusive, the possibility that high levels of plasma glucocorticoids may unfavourably affect the responsiveness of important neurons in critical regions of the brain to dopamine needs to be considered. According to the 'Dopamine Hypothesis' of schizophrenia, overactivity of dopamine neurons or heightened responsiveness of D 2 receptors to dopamine or both play an important role in the positive symptoms of the illness.
1,2 Recent evidence from PET scan studies, however, suggests that a reduced abundance or an underfunction of D 1 /D 5 receptors or both in the prefrontal cortex may link to the negative symptom of schizophrenia. 6 Taken together, it now appears that an overactivity of D 2 -like receptors and an underactivity of D 1 -like receptors or both may contribute to the pathophysiology of the illness. This is consistent with clinical observations as anti-psychotic drugs that block D 2 receptors are effective in alleviating positive symptoms 7, 8 whereas those enhancing the activity of D 1 -like receptors may improve negative symptoms. 9 Recently, we have reported that D 5 receptors and D 2 receptors co-exist in hypothalamic neurons producing atrial natriuretic factor or ANF. 10 Interestingly, dopamine, the common intrinsic ligand of D 5 and D 2 receptors, induces a biphasic response from the neurons, which involve an intricate interaction of the two receptors. 4 Whilst low concentrations of DA produce an opposing effect between the two receptors resulting in a functional inhibition, high levels of DA augment neuronal functions through a synergistic interaction of D 5 and D 2 receptors. It suggests that typical functions of these DA responsive neurons may involve a delicate balance between D 2 and D 5 receptor interaction in accordance with the availability of DA. A disruption of this equilibrium consequent to an augmented number of D 2 receptors or a reduced abundance of D 5 receptors induced presumably by some pathophysiological conditions, such as stress, may lead to a compromise in the functional integrity of these neurons. We here present evidence that glucocorticoids suppress D 5 receptor-mediated effects thereby adversely affecting the responsiveness of ANF neurons to dopamine by disrupting the interaction between D 5 and D 2 receptors.
In rat hypothalamic neuron cultures, 11, 12 DA induced biphasic changes in immunoreactive (ir)-ANF release ( Figure 1a ) over a wide range of concentrations (10 −9 to 10 −5 M) and in a ligand concentration-dependent manner. Previously, we have demonstrated that whilst the descending phase of the changes is mediated through D 2 receptors, the ascending phase involves an interaction between D 5 and D 2 receptors. 4 In the present studies, the effect of stress hormone, glucocorticoids, on the DA-induced biphasic changes in ANF neurons were and 10 −5 M) of DA. This resulted in a dose-related suppression of DA with an ED 50 of the amine approximately 10 −7 M (P Ͻ 0.05). The accentuated effect of DA suppression in the presence of DM was similar to that seen in cultures treated with quinpirole alone, a D 2 -like receptor agonist. 13 As the ascending phase of ir-ANF is mediated through the interaction of D 5 and D 2 receptors, 4 the findings suggest DM abolishes D 5 but not D 2 receptor-mediated effect; under these circumstances, the overall suppression effect of DA is likely to be mediated through the activation of D 2 receptors. Consistent with this notion is the observation that the suppression induced by low doses of DA (10 −9 to 10 −7 M), involving the activation of D 2 receptor alone was not affected by DM (Figure 1a) .
The DM inhibition of 10 −5 M of DA-stimulated ir-ANF release was both time-dependent and dose-related with the greatest effect found in cultures treated for 4 consecutive days ( Figure 1b ) and an ED 50 of 10 −10 M (Figure 1c ). At this concentration, DM suppressed DAstimulated ir-ANF secretion by approximately 50%.
It is noteworthy that DM inhibition of DA-induced stimulation was mimicked by corticosterone, an endogenous glucocorticoid of rat adrenocortical origin. At the physiological concentration of 10 −8 M (Figure 2a ), approximately two orders of magnitude greater than that of DM, corticosterone induced equivMolecular Psychiatry alent suppression of ir-ANF release. In contrast, the mineralocorticoid receptor agonist, deoxycorticosterone (DOC) at 10 −9 M failed to suppress DA-induced ir-ANF release (Figure 2a ). The specificity of DM inhibition was confirmed by its abolition with co-treatment with 10 −7 M of RU38486, a glucocorticoid receptor antagonist, but not by 10 −7 M of RU28318, a mineralocorticoid receptor antagonist (Figure 2b ). However, neither RU38486 nor RU28318 alone modulate ir-ANF release in cultures treated with or without DA.
To evaluate whether DM might also suppress the production of the peptide, the abundance of pro-ANF mRNA signals of the cultures were subjected to Northern blot analysis. In this series of studies, hypothalamic cultures were treated as described above except for a shorter incubation period of 4 h. The intensity of bands for pro-ANF mRNA signals in each lane was standardized to GAPDH mRNA, a constituent housekeeping gene. This was done by stripping ANF mRNA band from the membrane that was then reprobed with GAPDH antisense oligonucleotides ( Figure 3 ). Figure 3a shows that at the concentration of 10 −5 M, DA treatment enhances the abundance of pro-ANF mRNA. By itself, whereas DM did not affect the basal level of pro-ANF mRNA, 10 −10 M of the steroid suppressed high dose DA-induced increment of pro-ANF mRNA signals. This inhibitory effect of DM was blocked by coincubation with 10 −7 M of RU38486, a glucocorticoid receptor antagonist, but not by 10 −7 M of RU28318, a mineralocorticoid receptor antagonist (Figure 3a) . In contrast, DM failed to modulate lower concentrations In our present studies, the hypothalamic cultures were stimulated daily for 4 consecutive days so that the abundance of ir-ANF release could be determined by our RIA in a reproducible and confident manner. Whereas DA-induced biphasic changes of ir-ANF release may be due to alterations in DA receptor abundance following repeated DA exposures, it appears unlikely for the following reasons. First, in vehicletreated control or drug-naïve cultures subjected to the same 4-day experimental protocol, our in-house findings showed that an acute 15-min stimulation with DA induced a biphasic pattern of cAMP changes similar to that found in cultures treated repeatedly with DA. Secondly, our unpublished observations demonstrated that in these drug-naïve cultures, 4-h exposure to a single DA treatment also induced biphasic changes of pro-ANF mRNA abundance mimicking that seen in repeated DA-stimulated cultures. Since the changes of cAMP contents and pro-ANF mRNA abundance correlate well with the release of ir-ANF from our hypothalamic cultures, it is argued that in our present studies, alterations in the number and density of DA receptors do not contribute significantly to the biphasic responses of our hypothalamic cultures or ir-ANF release.
It is worthy of mention that whereas DM alone failed to modulate the basal release of ir-ANF, the synthetic glucocorticoid markedly suppressed the stimulatory effect of high doses of DA on ir-ANF release. The DM suppression is time-dependent and dose-related with an ED 50 of 10 −10 M. This concentration is consistent with that of DM required to affect a variety of glucocorticoid-regulated functions in various biological systems and is similar to the binding affinity of glucocorticoid receptors for DM.
14 Besides, the inhibitory effect of DM is also mimicked by physiological concentrations of corticosterone, a major adrenal glucocorticoid species of physiological relevance in the rat. It is important to point out that this effect of DM on 10 −5 M of DAinduced ir-ANF release is mediated specifically through the glucocorticoid receptor, as it is suppressed by the glucocorticoid receptor antagonist RU38486, but not RU28318, a mineralocorticoid receptor antagonist. The notion is also consistent with the observation that treatment with DOC, a mineralocorticoid receptor agonist, failed to suppress DA-induced ANF release. As the majority of ANF neurons in culture possess glucocorticoid receptors, 15 most of the neurons are considered glucocorticoid-sensitive and DM is likely to exert a direct effect on these cells. In contrast, DM has no significant effect on low concentrations (10 neurohormone is a potent inhibitor of water intake 16, 17 and thirst. Reduced synthesis and release of hypothalamic ANF have been implicated in polydipsia, an excessive water drinking disorder commonly seen in patients with chronic schizophrenia. It therefore raises the possibility that hypothalamic ANF neurons, like some of the DA-sensitive cells in critical regions of the brain, may also be affected in the disease. Whereas hypothalamic ANF neurons are unlikely to be involved in the negative symptoms of acute schizophrenic episode, the possibility that the novel mechanism described here may share similarity to that of neurons in the prefrontal cortex needs to be considered. The relevance of this process in relation to stress-induced changes warrants further investigation in animal models and clinical settings. If proven correct its ramification in better understanding the neurobiological basis of schizophrenia and the actions of anti-psychotic drugs may be substantial.
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Methods
Cell cultures
Neonatal rat hypothalamic cultures were prepared 11, 18, 19 by enzymatic dispersion of hypothalami removed from 2 to 3-day-old Sprague-Dawley rat pups. The dispersed cells were maintained in Hepes buffered Dulbecco's Modified Eagle's Medium (HDME) supplemented with 8% fetal calf serum at 37°C in 10% CO 2 . All release studies were conducted on the seventh day of culture and extended over a period of 4 days. The drugs were applied every 24 h to the cultures. Four hours after the last application of vehicle or drugs, conditioned media were removed and extracted for immunoreactive (ir) ANF release measurement by double antibody radioimmunoassay (RIA). [20] [21] [22] Each of the experiments was performed at least three times; within a study, the results of an individual condition represented the average of three to four cultured wells. Results presented here are the mean of three or more separate experiments from different batches of cell preparations.
Radioimmunoassay of ANF
Rabbit anti-ANF antiserum (R178) was used in the heterologous double antibody RIA system as previously described 11, [20] [21] [22] for the estimation of ir-ANF levels in culture media. Synthetic rat (r)ANF1-28 was used for both standards and radioiodination. The antiserum (R178) raised against synthetic hANF1-28 recognises the amino acid sequence of 5-25 with the amino acid 12 (Ile) as part of an epitope; it thus cross-reacts 65% with synthetic rANF1-28, rANF4-28, rANF4-27, rANF5-28 and rANF5-27. The antiserum does not recognise brain natriuretic peptide (BNP), type-C natriuretic peptide (CNP), B-endorphin, enkephalin, vasopressin, angiotensin I and II. At a final dilution of 1:42 000, the antiserum yielded a specific binding of 28% with a sensitivity of 2 pg tube −1 and ED 50 of 62 pg. The intra-and interassay co-efficients of variation were 5% and 8% respectively.
Northern blot analysis
Following treatment, cells were lysed directly in the well by adding 0.5 ml of Trizol Reagent (Life Technologies, Grand Island, NY, USA). The cell lysate from three individual wells, each with 10 6 cells, were harvested by pipetting and pooled together as a single sample for the study. The cytoplasmic RNA was further extracted by chloroform and precipitated with isopropyl alcohol. Twelve micrograms of total RNA from each of the samples fractionated by electrophoresis through formaldehyde-agarose gel were transferred to nylon membrane and hybridized with digoxigeninlabeled ANF-antisense oligonucleotide probes [23] [24] [25] and visualized by colorimetric reaction. The signals of individual bands for pro-ANF mRNA were measured as integrated intensity by a computer based Image-Pro Plus version 3 (Media Cybernetics, Maryland, USA) taking the vehicle-treated controls as 100% for statistical comparison. After signal analysis, the same blots were reprobed with digoxigenin-labeled GAPDH mRNA oligonucleotide. The integrated intensity of each band of pro-mRNA from various treatment groups was adjusted to that of corresponding bands of GAPDH mRNA; the values were then expressed as a percentage of that of the vehicle-treated controls.
